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To define the mechanism(s) of carcinogen depletion of Lan-
gerhans cells (LC) from skin, the migration of LC from the 
skin to the regional lymph node was examined in carcino-
gen-treated, antigen-treated, and control sheep. This was 
assessed by cannulation of afferent lymphatic vessels that 
drain the treated areas of skin or the efferent lymphatic 
draining the regional lymph node. Cells draining from test or 
control skin were continuously collected and enumerated by 
indirect immunofluorescence and flow cytometry using spe-
cific anti-COl monoclonal antibodies . 
There was a marked increase in the rate ofLC migration in 
I t has been previously demons~rated th.at treatment o~ murine skin with the complete chemical carc1l10gen 7,12-dlmethyl-benz(a)anthracene (DMBA) resulted in a marked depletion of LC within the treated area [1]. This LC depletion was evident 3 - 4 d after application of the carcinogen. It has been 
demonstrated that administration of antigen through LC depleted 
skin results in the induction of tolerance to the antigen [2]. This 
also highlights the im~ortant role that these. cells normally play 
in presentation to the Immune system of antigens that enter the 
skin. 
The question of whether this LC de~letion. was due to. cell death 
or migration of these cells from the epidermiS has rema1l1ed unre-
solved, although a detailed examination of skin sections and epider-
mal sheets by both histology and electron microscopy failed to show 
any evidence of cell death. Thi~ led to .the pro~osal. that such a 
depletion ofLC resulted from an1l1crease 111 cell migration from the 
epidermis [1]. 
We have used sheep as a model to assess the effect of DMBA on 
LC migration from skin. Sheep provide unique opportunities to 
examine these aspects of LC physiology as the relative size and 
accessibility of the lymphatic vessels that drain the skin of sheep 
allows cannulation and, therefore, direct sampling and analysis of 
the cells that migrate from the skin to the regional lymph node. It 
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Abbreviations: 
DC: dendritic cells 
DMBA: 7, 12-dimethylbenz(a)anthracene 
FITC: fluorescein isothiocyanate 
GM-CSF: granulocyte/macrophage colony-stimulating factor 
IL: Interleukin 
IU: International Units 
LC: Langerhans cells 
TNCB: 2,4,6-trinitrochlorobenzene 
TNF: tumor necrosis factor 
the 8 h following the application of the contact sensitizing 
antigen trinitrochlorobenzene (TNCB). The chemical car-
cinogen 7, 12-dimethylbenz(a)anthracene (DMBA) trig-
gered a tenfold-greater migration of LC compared with 
TNCB-with the peak response at 5 d. After DMBA treat-
ment LC were also detected in the efferent lymph of the 
regional lymph node. 
It is concluded that the depletion of LC from carcinogen-
treated skin is due to the increased LC migration and not 
carcinogen-induced cell death. ] Invest Dermatol 99:515-
535, 1992 
has previously been reported that between 20 and 30% of the cells in 
peripheral sheep lymph are of the macrophage/monocyte lineage, 
ranging from typical monocytes to those described as "veiled" or 
"frilly" cells [3]. Other investigators have suggested that these so-
called "veiled cells" are LC [4]. Our own investigations* have 
shown that, under normal circumstances, approximately 4% of the 
cells in afferent lymph draining the skin are LC. 
Recent experiments* have shown that there is an increase in the 
rate of .migration of antigen-presenting LC from the epidermis to 
the regional lymph node of sheep following the topical application 
of either the complete chemical carcinogen DMBA or the contact-
sensitizing antigen 2,4,6-trinitrochlorobenzene (TNCB). In each 
case, the rate of LC migration was found to increase immediately 
after treatment. This effect would appear to be consistent with the 
normal role of antigen presentation associated with these cells. 
When TNCB was applied to the skin, the majority of LC that 
migrated did so within 24 h of treatment (Fig 1). This was followed 
by a seco~ld smaller peak ofLC migration during the following 3 d, 
after which the pattern of LC migration returned to the normal 
level. The rapid induction of the initial migration of the LC ob-
served here is consistent with earlier reports showing a moderate 
increase in the number of dendritic cells (including Langerhans 
cells~ 111. the draining lymph node within 30 min of the topical 
applIcatIOn of the contact-sensitizing agent fluorescein isothio-
cyanate (FITC) [5]. The number of dendritic cells within the drain-
ing lymph node after the topical application of FITC peaked after 
4 h at a level that was maintained for 2 d, before returning to near 
normal by day 4. 
When the complete chemical carcinogen DMBA was applied to 
the skin the rate of LC migration showed an immediate though 
moderate increase. This increase was approximately one third the 
size of that which followed the application ofTNCB (i.e., 1 X 106 
LC/h and 3 X 106 LC/h, respectively). The great majority of LC 
* Dandie GW, Watkins FY, Ragg S], Holloway PE, Muller HK: The 
migration of Langer hans cells into and out oflymph nodes draining normal, 
carcinogen and antigen treated sheep skin (submitted). 
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Figure 1. Number of Langerhans cells migrating per hour via afferent 
lymphatics from TNCB-treated sheep flank skin. 
that migrated away from DMBA-treated skin did so approximately 
4-5 d after application of the carcinogen, when up to 3.5 X 107 
LC/h migrated from the treated skin to the regional lymph node 
(Fig 2). The time of greatest LC migration was similar to that at 
which LC depletion had been previously observed in the dorsal skin 
of DMBA-treated mice [1] . This peak in LC migration was also 
associated with the detection oflarge numbers ofLC in the efferent 
lymph draining the regional lymph node (Fig 3). 
It is evident that the effects of DMBA application to skin differ 
from those that follow treatment with TNCB not only in relative 
magnitude, but also in the times at which the majority of LC are 
triggered to migrate away from treated skin. As both agents induce 
a rapid increase in LC migration that is followed by a second 
peak some days later this indicates that similar, as yet unidentified, 
regulatory mechanisms may be initially involved in each case. 
This is supported by the similar size of the initial increase in LC 
migration that follows the application of either DMBA or 
TNCB. 
The profound difference in the magnitude of the major DMBA-
~nduced peak at 4 - 5 d indicates th~t there are important differences 
111 the effects of DMBA and antigen on LC metabolism and/or 
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Figure 2. Number of Langerhans cells migrating per hour via afferent 
lymphatics from DMBA- or lanolin/paraffin vehicle-treated sheep flank 
skin. 
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Figure 3. Number of Langerhans cells migrating per hour through the 
draining lymph node and into the efferent lymph after topical application of 
DMBA. 
function. The time at which the greatest number of LC migrated 
away from the skin after application ofDMBA suggests some direct 
action of the carcinogen on LC triggering their enhanced rate of 
migration. Alternatively, DMBA may affect some other cell type(s) 
within the skin that in turn signal the LC to migrate. 
The initial signal that triggers LC migration may result from 
direct activat~on o~ these cells by antigen or what is initially per-
ceived as antigen 111 the case of DMBA. The different migration 
patterns may reflect different cytokine production/secretion pro-
files from other cells in the skin, such as keratinocytes, which are 
known to pro?uce IL-l [6], IL-6 [7], TNFa [8], and GM-CSF [9]. 
The disruptIOn of the epidermal LC network by DMBA-induced 
depletion of these cells, like UV irradiation, has already been shown 
to cause a functional impairment of the skin immune system 
[~, 10, 11]. As the m~gnitude of the LC migration response is suffi-
cient to cause depletion of these cells, any foreign antigen adminis-
tered via DMBA-treated skin at or shortly after the time of maxi-
mum LC migration (i.e., 4- 5 d post-treatment) would result in the 
induction of tolerance and not immunity. 
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